Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Tudor Pickering Initiates Coverage On Blink Charging with Hold Rating

Tudor Pickering analyst Oliver Huang initiates coverage on Blink Charging (NASDAQ:BLNK) with a Hold rating.

byBenzinga Newsdesk

April 21, 2022

1 minute read

Tudor Pickering analyst Oliver Huang initiates coverage on Blink Charging (NASDAQ:BLNK) with a Hold rating.

USA Industrial Production (MoM) for Jul 0.900% vs 0.500% Est; Prior Revised from 0.400% to 0.200%

By Benzinga Newsdesk

Today, 1:06 PM

USA Industrial Production (MoM) for Jul 0.900% vs 0.500% consensus estimate. The prior reading was revised from an initial 0.400% to 0.200%.

SPY

Morgan Stanley Maintains Overweight on Ally Financial, Raises Price Target to $75

By Benzinga Newsdesk

Today, 1:06 PM

Morgan Stanley analyst Betsy Graseck maintains Ally Financial (NYSE:ALLY) with a Overweight and raises the price target from $71 to $75.

ALLY

F-star Therapeutics Stock Jumps On Licensing Pact For STING Inhibitors With AstraZeneca

By Vandana Singh

Today, 1:06 PM

F-star Therapeutics Inc (NASDAQ:FSTX) has entered into an exclusive licensing agreement with AstraZeneca plc (NASDAQ:AZN) for research, development, and commercialization of next-generation Stimulator…

AZN

Raymond James Maintains Strong Buy on Dollar General, Raises Price Target to $260

By Benzinga Newsdesk

Today, 1:06 PM

Raymond James analyst Bobby Griffin maintains Dollar General (NYSE:DG) with a Strong Buy and raises the price target from $235 to $260.

Tudor Pickering Initiates Coverage On Blink Charging with Hold Rating

Related Posts

USA Industrial Production (MoM) for Jul 0.900% vs 0.500% Est; Prior Revised from 0.400% to 0.200%

Morgan Stanley Maintains Overweight on Ally Financial, Raises Price Target to $75

F-star Therapeutics Stock Jumps On Licensing Pact For STING Inhibitors With AstraZeneca

Raymond James Maintains Strong Buy on Dollar General, Raises Price Target to $260